Literature DB >> 26083274

Biobanking multifocal breast carcinomas: sample adequacy with regard to histology and DNA content.

Gyula Pekar1, Hanna Davies2, Agnes P Lukacs1, Lars Forsberg2, Dan Hellberg3, Jan Dumanski2, Tibor Tot1.   

Abstract

AIMS: To determine the volume of tumoral and normal breast tissue containing sufficient DNA (>2 μg/sample) for genetic platforms and biobanking, with a focus on multifocality, tumoral heterogeneity, and factors that critically influence sample acceptability. METHODS AND
RESULTS: We examined 57 breast surgical specimens with multifocal (46/57) and unifocal (11/57) cancers. Punch biopsies were obtained from tissue slices under multimodal radiological guidance, and the colour-coded sampling sites were identified in large-format histology slides. The study comprised 415 DNA isolations from tumour (n = 105) and normal (n = 283) tissue, including skin (n = 27) samples. A single 2-mm core from invasive tumour contained sufficient DNA in 91.4% (96/105) of cases, depending on tumour type (3.8-108.2 μg/sample), number and size of additional foci in multifocal cases (P = 0.001), tumour consistency, and degree of necrosis. Three biopsies obtained with a 4-mm device were required from normal breast tissue, at least 10 mm from the tumour. Cold ischaemia for up to 82 min did not influence the yield of DNA.
CONCLUSIONS: Radiological disease mapping is useful for guiding optimal specimen slicing and for targeting breast lesions. A single 2-mm core from tumour and multiple 4-mm cores from normal breast tissue yield adequate DNA in the majority of samples.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  DNA quality and quantity; biobanking; breast cancer; heterogeneity; multifocality

Mesh:

Substances:

Year:  2015        PMID: 26083274     DOI: 10.1111/his.12758

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  2 in total

1.  Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer.

Authors:  Lars A Forsberg; Chiara Rasi; Gyula Pekar; Hanna Davies; Arkadiusz Piotrowski; Devin Absher; Hamid Reza Razzaghian; Aleksandra Ambicka; Krzysztof Halaszka; Marcin Przewoźnik; Anna Kruczak; Geeta Mandava; Saichand Pasupulati; Julia Hacker; K Reddy Prakash; Ravi Chandra Dasari; Joey Lau; Nelly Penagos-Tafurt; Helena M Olofsson; Gunilla Hallberg; Piotr Skotnicki; Jerzy Mituś; Jaroslaw Skokowski; Michal Jankowski; Ewa Śrutek; Wojciech Zegarski; Eva Tiensuu Janson; Janusz Ryś; Tibor Tot; Jan P Dumanski
Journal:  Genome Res       Date:  2015-10       Impact factor: 9.043

2.  Comprehensive cancer-oriented biobanking resource of human samples for studies of post-zygotic genetic variation involved in cancer predisposition.

Authors:  Natalia Filipowicz; Kinga Drężek; Monika Horbacz; Agata Wojdak; Jakub Szymanowski; Edyta Rychlicka-Buniowska; Ulana Juhas; Katarzyna Duzowska; Tomasz Nowikiewicz; Wiktoria Stańkowska; Katarzyna Chojnowska; Maria Andreou; Urszula Ławrynowicz; Magdalena Wójcik; Hanna Davies; Ewa Śrutek; Michał Bieńkowski; Katarzyna Milian-Ciesielska; Marek Zdrenka; Aleksandra Ambicka; Marcin Przewoźnik; Agnieszka Harazin-Lechowska; Agnieszka Adamczyk; Jacek Kowalski; Dariusz Bała; Dorian Wiśniewski; Karol Tkaczyński; Krzysztof Kamecki; Marta Drzewiecka; Paweł Wroński; Jerzy Siekiera; Izabela Ratnicka; Jerzy Jankau; Karol Wierzba; Jarosław Skokowski; Karol Połom; Mikołaj Przydacz; Łukasz Bełch; Piotr Chłosta; Marcin Matuszewski; Krzysztof Okoń; Olga Rostkowska; Andrzej Hellmann; Karol Sasim; Piotr Remiszewski; Marek Sierżęga; Stanisław Hać; Jarosław Kobiela; Łukasz Kaska; Michał Jankowski; Diana Hodorowicz-Zaniewska; Janusz Jaszczyński; Wojciech Zegarski; Wojciech Makarewicz; Rafał Pęksa; Joanna Szpor; Janusz Ryś; Łukasz Szylberg; Arkadiusz Piotrowski; Jan P Dumanski
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.